Mereo BioPharma Group Plc (MREO)
0.2764
+0.01
(+3.60%)
USD |
NASDAQ |
Sep 01, 16:00
0.2711
-0.01
(-1.92%)
After-Hours: 20:00
Mereo BioPharma Group Cash from Operations (TTM) : -25.28M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.28M |
| March 31, 2026 | -26.99M |
| December 31, 2025 | -31.04M |
| September 30, 2025 | -32.70M |
| Date | Value |
|---|---|
| June 30, 2025 | -33.07M |
| March 31, 2025 | -33.22M |
| December 31, 2024 | -32.85M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -7.385M |
| NuCana Plc | -6.332M |
| BioNTech SE | 725.62M |
| Silence Therapeutics Plc | -41.79M |
| Autolus Therapeutics Plc | -224.98M |